DK422589A - Farmaceutisk praeparat til behandling af immundefekttilstande - Google Patents

Farmaceutisk praeparat til behandling af immundefekttilstande

Info

Publication number
DK422589A
DK422589A DK422589A DK422589A DK422589A DK 422589 A DK422589 A DK 422589A DK 422589 A DK422589 A DK 422589A DK 422589 A DK422589 A DK 422589A DK 422589 A DK422589 A DK 422589A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
treatment
defective conditions
immune defective
immune
Prior art date
Application number
DK422589A
Other languages
English (en)
Other versions
DK422589D0 (da
DK175381B1 (da
Inventor
German Mikhailovich Yakolev
Vyacheslav Grigorievic Morozov
Vladimir Khatskelevi Khavinson
Vladislav Isakovich Deigin
Andrei Marxovich Korotkov
Original Assignee
Vsesojuznyj Kardiologitsches
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsesojuznyj Kardiologitsches filed Critical Vsesojuznyj Kardiologitsches
Publication of DK422589D0 publication Critical patent/DK422589D0/da
Publication of DK422589A publication Critical patent/DK422589A/da
Application granted granted Critical
Publication of DK175381B1 publication Critical patent/DK175381B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK198904225A 1987-12-30 1989-08-28 Farmaceutisk præparat til behandling af immundefekttilstande DK175381B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SU4352833 1987-12-30
SU4352833 1987-12-30
SU8800255 1988-12-14
PCT/SU1988/000255 WO1989006134A1 (en) 1987-12-30 1988-12-14 Pharmaceutical preparation for treating immunodeficiency conditions

Publications (3)

Publication Number Publication Date
DK422589D0 DK422589D0 (da) 1989-08-28
DK422589A true DK422589A (da) 1989-08-28
DK175381B1 DK175381B1 (da) 2004-09-20

Family

ID=21346062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198904225A DK175381B1 (da) 1987-12-30 1989-08-28 Farmaceutisk præparat til behandling af immundefekttilstande

Country Status (9)

Country Link
US (2) US5538951A (da)
EP (1) EP0346501B1 (da)
JP (1) JP2511159B2 (da)
AT (1) ATE78696T1 (da)
AU (1) AU616236B2 (da)
CA (1) CA1330300C (da)
DE (1) DE3873327D1 (da)
DK (1) DK175381B1 (da)
WO (1) WO1989006134A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5189016A (en) * 1990-05-18 1993-02-23 Clintec Nutrition Co. Nutrient compositions containing peptides and method for administering the same
US5122515A (en) * 1990-06-19 1992-06-16 Smith Ross C Nutrient composition containing dipeptides and method for administering the same
ATE188219T1 (de) * 1991-10-28 2000-01-15 Cytran Ltd Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden.
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
AU6359594A (en) * 1993-03-04 1994-09-26 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
RU2107692C1 (ru) * 1995-06-07 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
RU2107691C1 (ru) 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US6103699A (en) 1996-06-07 2000-08-15 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6159940A (en) * 1996-02-28 2000-12-12 Immunotech Developments Inc. Method for modulating hemopoiesis
US6060452A (en) * 1996-03-13 2000-05-09 Cytran, Inc. Analogs of L-Glu-L-Trp having pharmacological activity
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
EP1840133A1 (en) 2006-03-29 2007-10-03 Global Biotech Development Corp. Ltd. New immunomodulating oligopeptides
CN110869041A (zh) 2017-11-08 2020-03-06 奥尼佩普学会 在糖尿病足的情况下增强组织氧合的医药制剂及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
JPS58121259A (ja) * 1982-01-09 1983-07-19 Microbial Chem Res Found ベスタチン新規誘導体
US4751216A (en) * 1985-12-26 1988-06-14 Imreg, Inc. Methods for treating AIDS and ARC
US4699898A (en) * 1985-12-26 1987-10-13 Imreg, Inc. Tripeptides affecting immune response
US4710380A (en) * 1986-04-04 1987-12-01 Imreg, Inc. Treatment of autoimmune disorders with immunoamplifiers

Also Published As

Publication number Publication date
EP0346501A1 (de) 1989-12-20
DK422589D0 (da) 1989-08-28
US5767087A (en) 1998-06-16
US5538951A (en) 1996-07-23
ATE78696T1 (de) 1992-08-15
JP2511159B2 (ja) 1996-06-26
WO1989006134A1 (en) 1989-07-13
AU2930889A (en) 1989-08-01
EP0346501A4 (en) 1990-09-05
DE3873327D1 (de) 1992-09-03
CA1330300C (en) 1994-06-21
DK175381B1 (da) 2004-09-20
EP0346501B1 (de) 1992-07-29
AU616236B2 (en) 1991-10-24
JPH02502826A (ja) 1990-09-06

Similar Documents

Publication Publication Date Title
DK422589D0 (da) Farmaceutisk praeparat til behandling af immundefekttilstande
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
DK162965C (da) Anvendelse af et difluornucleosid eller et farmaceutisk acceptabelt salt deraf til fremstilling af et laegemiddel til behandling af neoplasma
DE3763603D1 (de) Trimerisierungsverfahren.
NO873598L (no) Kirurgisk protese.
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
DE3787587D1 (de) Formerkennungsverfahren.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO870240L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
DK336688D0 (da) Nucleosider od fremgangsmaade til fremstilling deraf
DK524788A (da) Anvendelse af morphin-antagonister til fremstilling af laegemidler med immunomodulerende og antiviral effekt, isaer til behandling af erhvervede immundefekt-tilstande
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
DE3861709D1 (de) Anti-hiv-mittel und methode zu deren erzeugung.
NO870533D0 (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
DE3763507D1 (de) Patientenlagerungstisch.
DE3763140D1 (de) Patientenlagerungstisch.
EP0235904A3 (en) Treatment of allergy with thymopentin
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
PT91610A (pt) Process for the preparation of compounds for the treatment of arteritis rheumatoidal
EP0265338A3 (en) Stable therapeutical compositions based on hydrophobic vegetable oil, and process for preparing them
DE3853551D1 (de) Plasmabehandlungsvorrichtung.
NO891691D0 (no) Rekombinant gag-forloeper for hiv.
NO871484D0 (no) Fremgangsmaate for fremstilling av n-(sulfonylmetyl) formamider.
TR23141A (tr) Oksodiazolon tuerevi bunun hazirlanma prosesi,ve bunu ihtiva eden herbisid
DK72088D0 (da) Oximethere af 2,6-dioxabicyclo(3.3.0)octanoner og farmaceutiske praeparater til behandling af hjerte- og blodkredsloebssygdomme

Legal Events

Date Code Title Description
PUP Patent expired